Cysteamine might be a treatment for Huntington’s Disease

Huntington’s Disease is a neurological condition that can bring on intellectual deterioration, leading to dementia. It is accompanied by symptons of depression and involuntary abnormal body movements. It is a rare condition that usually occurs between the ages of 35 and 50 years, often leading to death in the following 15 to 20 years.

Researchers at the Institut Curie, CNRS and Inserm have shown that cysteamine, which is already used to treat Cystinosis, can help prevent the death of neurons in the brain and hence be used to treat Huntington’s Disase.

More on this research can be found at http://www.innovations-report.de.

Comments are closed.

Jonathan Terry Has Sadly Passed Away We are very sad to report that our founder, Jonathan Terry, died peacefully in his sleep on 9th [...] Read more...
10th March 2019 – Movie Music Magic Concert On 10th March 2019 the Cinematic Syncopations Orchestra are hosting an afternoon of music from [...] Read more...
Cystinosis Comic Book Series by Artist Kevin McCalla The Cystinosis Research Network in the US has teamed up with Kevin McCalla, a young artist who [...] Read more...
Newsletter – November 2012 Issue 21 of the Foundation newsletter has recently been finalised and is available to download [...] Read more...
All website content copyright Cystinosis Foundation UK (Charity No.1074885) 1997-2013, except where explicitly stated.
Data Protection Act Registration Number: Z9880997. Please refer to our terms and conditions and our privacy policy.
site:bonnyday